Literature DB >> 19649731

Mutation screening of VHL gene in a family with malignant bilateral pheochromocytoma: from isolated familial pheochromocytoma to von Hippel-Lindau disease.

Shirin Hasani-Ranjbar1, Mahsa M Amoli, Azadeh Ebrahim-Habibi, Vahid Haghpanah, Maryam Hejazi, Akbar Soltani, Bagher Larijani.   

Abstract

von Hippel-Lindau (vHL) disease is an inherited, autosomal dominant syndrome manifested by a variety of benign and malignant tumors. More than 300 germline VHL mutations have been identified that are involved in VHL disease. A large family (four generations) was evaluated. In this paper we report the presence of a single nucleotide mutation in exon 3 of VHL gene c499 C>T causing substitution of Arginine by Tryptophan at position 167 (R 167 W). It was detected in a family with bilateral malignant pheochromocytoma who has been followed for at least 9 years as RET negative isolated familial pheochromocytoma, finally diagnosed as von Hipple-Lindau disease according to retinal angioma and VHL gene mutation. VHL type 2 presenting with both pheochromocytoma and retinal angioma in this family found to be associated with the new missense mutation (c499 C>T) of VHL gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19649731     DOI: 10.1007/s10689-009-9266-4

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  30 in total

Review 1.  Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.

Authors:  K Pacak; W M Linehan; G Eisenhofer; M M Walther; D S Goldstein
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

2.  Familial nonsyndromic pheochromocytoma.

Authors:  Giuseppe Opocher; Francesca Schiavi; Maurizio Iacobone; Antonio Toniato; Sabina Sattarova; Zoran Erlic; Maddalena Martella; Caterina Mian; Isabella Merante Boschin; Laura Zambonin; Paola De Lazzari; Alessandra Murgia; Maria Rosa Pelizzo; Gennaro Favia; Franco Mantero
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

3.  Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.

Authors:  B Zbar; T Kishida; F Chen; L Schmidt; E R Maher; F M Richards; P A Crossey; A R Webster; N A Affara; M A Ferguson-Smith; H Brauch; D Glavac; H P Neumann; S Tisherman; J J Mulvihill; D J Gross; T Shuin; J Whaley; B Seizinger; N Kley; S Olschwang; C Boisson; S Richard; C H Lips; M Lerman
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

4.  Molecular analysis of the Von Hippel-Lindau (VHL) gene in a family with non-syndromic pheochromocytoma: the importance of genetic testing.

Authors:  Juliana B Cruz; Leonardo P S Fernandes; Sueli A Clara; Sandro J Conde; Denise Perone; Peter Kopp; Célia R Nogueira
Journal:  Arq Bras Endocrinol Metabol       Date:  2007-12

Review 5.  Molecular basis of the VHL hereditary cancer syndrome.

Authors:  William G Kaelin
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

6.  Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.

Authors:  C E Stebbins; W G Kaelin; N P Pavletich
Journal:  Science       Date:  1999-04-16       Impact factor: 47.728

Review 7.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

8.  NOMAD-Ref: visualization, deformation and refinement of macromolecular structures based on all-atom normal mode analysis.

Authors:  Erik Lindahl; Cyril Azuara; Patrice Koehl; Marc Delarue
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

9.  A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C.

Authors:  Jennifer M J Schreinemakers; Bernard A Zonnenberg; Jo W M Höppener; Frederik J Hes; Inne H M Borel Rinkes Rinkes; Cornelis J M Lips
Journal:  World J Surg Oncol       Date:  2007-10-08       Impact factor: 2.754

10.  Ser80Ile mutation and a concurrent Pro25Leu variant of the VHL gene in an extended Hungarian von Hippel-Lindau family.

Authors:  Attila Patocs; Peter Gergics; Katalin Balogh; Miklos Toth; Ferenc Fazakas; Istvan Liko; Karoly Racz
Journal:  BMC Med Genet       Date:  2008-04-16       Impact factor: 2.103

View more
  6 in total

1.  A new frameshift MEN1 gene mutation associated with familial malignant insulinomas.

Authors:  Shirin Hasani-Ranjbar; Mahsa M Amoli; Azadeh Ebrahim-Habibi; Mohammad Hossein Gozashti; Nahid Khalili; Forugh A Sayyahpour; Jila Hafeziyeh; Akbar Soltani; Bagher Larijani
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

2.  Practical evaluation of late-night salivary cortisol: a real-life approach.

Authors:  Shirin Hasani-Ranjbar; Mahsa M Amoli
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

3.  Changing pattern of pheochromocytoma and paraganglioma in a stable UK population.

Authors:  I T Cvasciuc; S Gull; R Oprean; K H Lim; F Eatock
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jan-Mar       Impact factor: 0.877

4.  Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine.

Authors:  Shailendra Dwivedi; Purvi Purohit; Radhieka Misra; Puneet Pareek; Apul Goel; Sanjay Khattri; Kamlesh Kumar Pant; Sanjeev Misra; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2017-08-22

5.  Clinical and Laboratory Characteristics of a Large Iranian Kindred Afflicted with Von Hippel Lindau Disease.

Authors:  Ali Asghar Mir Saeid Ghazi; Atieh Amouzegar; Azita Zadeh-Vakili; Abdolreza Sheikh Rezaei; Alireza Amirbaigloo; Marjan Zarif Yeganeh; Hasan Hashemi; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2021-03-16

6.  Von hippel-lindau disease: a new approach to an old problem.

Authors:  Ali Tootee; Shirin Hasani-Ranjbar
Journal:  Int J Endocrinol Metab       Date:  2012-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.